Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1897 of 5804
-
Can online CBT help veterans at risk for suicide?
Symptom relief Recruiting nowThis study plans to learn more about the use of one of two self-guided online cognitive behavioral therapy courses. One is focused on symptoms of depression and one is focused on history of suicidal thoughts and behaviors.
Phase: PHASE2 • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
VR treadmill trial aims to help stroke survivors walk and think better
Disease control Recruiting nowThis was a single-blind randomized controlled trial of multisensory stimulation virtual reality to improve motor and cognitive dysfunction in stroke patients.
Phase: NA • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Gene-Guided cancer care: does expert advice change treatment?
Knowledge-focused Recruiting nowThis is a single-arm Phase II study to measure the impact of Molecular Tumor Board treatment recommendations on treatment decision-making in clinical practice at the Dartmouth Cancer Center. Following tumor genetic profiling, subjects will be screened for eligibility. Eligible su…
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Small wishes, big comfort: new program brings dignity to End-of-Life care
Symptom relief OngoingDignified and compassionate end-of-life (EOL) care is a cornerstone of high-quality, patient-centered care, but in safety-net hospitals EOL care is often overlooked, considered too late, or not at all. By eliciting and implementing final wishes for dying patients, the 3 Wishes Pr…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
AI could predict which ICU patients with breathing failure are at highest risk of death
Knowledge-focused CompletedAcute hypoxemic respiratory failure (AHRF) is the most common cause of admission in the intensive care units (UCIs) worldwide. We will assess the value of machine learning (ML) techniques for early prediction of ICU death in 1,241 patients enrolled in the PANDORA (Prevalence AND …
Sponsor: Hospital Universitario de Gran Canaria Doctor Negrín • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Could a daily iron pill boost energy in heart failure?
Disease control Recruiting nowThe goal of this study is to investigate the effect of oral sucrosomial iron on exercise capacity and quality of life in patients with heart failure (HF) and iron deficiency (ID). The main question the study aims to answer is whether oral sucrosomial iron improved exercise capac…
Phase: PHASE4 • Sponsor: Raffaele De Caterina • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New cancer drug HLX42 enters first human trial
Disease control Recruiting nowThis study is an open-label first-in-human phase I clinical study to evaluate the safety and tolerability of HLX42.
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
NICU GERD trial: which therapy helps babies feed better?
Disease control Recruiting nowThe goal of this investigator-initiated, single-center, randomized controlled trial (RCT) is to compare the effects of four weeks of three therapies on clinical and mechanistic outcomes based on pH-Imp testing using a three-arm parallel design in NICU infants with objective GERD …
Phase: NA • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Glowing dye could help surgeons remove sarcomas in one go
Diagnosis Recruiting nowThis study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Virtual clinic aims to reverse 'ICU Brain' in survivors of critical illness
Disease control Recruiting nowIntact cognitive skills are necessary for independent living, going to work, and managing finances, and any loss of cognitive skills places a burden on society akin to what is seen with Alzheimer's Disease and Related Dementias. The TelePORT Study (Telehealth-Enhanced Patient-Ori…
Phase: NA • Sponsor: Vanderbilt University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug combo aims to tackle tough blood cancer
Disease control Recruiting nowSystemic mastocytosis with an associated hematologic neoplasm (SM-AHN) is a challenging disease to treat. Targeted KIT inhibitors have been approved for this indication based on their ability to control the mastocytosis portion of the disease, but patients frequently experience p…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Mailed test kits aim to boost colon cancer screening in underserved brooklyn
Prevention ENROLLING_BY_INVITATIONThe purpose of the study is to boost colorectal cancer (CRC) screening rates in an underserved population in Brooklyn through organized, proactive outreach of mailed Fecal Immunochemical Tests (FIT), utilizing evidence-based interventions tailored to the needs of the population.
Phase: NA • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Could this sleep drug help Alzheimer's patients rest better?
Symptom relief Recruiting nowDARIDOR-ALZ is a phase IV clinical trial designed to evaluate both the efficacy and safety of daridorexant, a selective dual orexin receptor antagonist that blocks the actions of the orexin neuropeptides at both orexin-1 and orexin-2 receptors, in selected populations of MCI and …
Phase: PHASE4 • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could your smartphone detect a heart attack? new study aims to find out.
Diagnosis Recruiting nowAliveCor (www.alivecor.com) has developed several electrocardiogram (ECG) devices that interface with iOS and Android smartphones and tablets via various Kardia apps. The current Kardia family of devices can measure single lead and six limb-lead ECGs, depending on the device. Kar…
Phase: NA • Sponsor: AliveCor • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New DNA test could speed up bone infection diagnosis
Diagnosis CompletedThe value of next-generation sequencing (NGS) using Nanopore technology has been demonstrated in the case of diabetic patients' wounds or in prosthetic joint infections. The aim of this study is to demonstrate its relevance as a new diagnostic approach for fracture-related infect…
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a heart drug ease long COVID symptoms?
Symptom relief CompletedThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This protocol is a prospective, mu…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a cancer drug shrink tumors in men with a key gene loss?
Disease control OngoingThe goal of this clinical trial is to test the anti-tumor activity of bortezomib in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC) with PTEN Deletion. The main question\[s\] it aims to answer is if the use of bortezomib will result in a decline in PSA …
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Massive registry launches to track heart ablation outcomes
Disease control Recruiting nowThe primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Sponsor: AtriCure, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Swiss study tests if pharmacy cannabis reduces smoking risks
Disease control OngoingThough regulated cannabis sales are increasing, little is known about the individual health effects of cannabis regulation. Data from countries with a regulated market can be used to test the effect of regulation on the price of cannabis in the illicit market, and to explore its …
Phase: NA • Sponsor: University of Bern • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Opioid-Free anesthesia: a safer way to go under the knife?
Symptom relief Recruiting nowOpioid-free anesthesia (OFA) is a multimodal technique that eliminates intraoperative opioids by combining dexmedetomidine, ketamine, lidocaine, NSAIDs, and regional analgesia. Growing evidence suggests OFA reduces postoperative opioid consumption, opioid-related adverse effects,…
Phase: NA • Sponsor: Jagiellonian University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC